BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Troy AM, Sheahan K, Mulcahy HE, Duffy MJ, Hyland JM, O’Donoghue DP. Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression. Eur J Cancer. 2004;40:1610-1616. [PMID: 15196548 DOI: 10.1016/j.ejca.2004.03.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Vižin T, Christensen IJ, Wilhelmsen M, Nielsen HJ, Kos J. Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients. BMC Cancer 2014;14:259. [PMID: 24725597 DOI: 10.1186/1471-2407-14-259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
2 Munikishore R, Wang LL, Zhang S, Zhao QS, Zuo Z. An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94. Bioorg Chem 2021;116:105317. [PMID: 34488126 DOI: 10.1016/j.bioorg.2021.105317] [Reference Citation Analysis]
3 Gormley JA, Hegarty SM, O'Grady A, Stevenson MR, Burden RE, Barrett HL, Scott CJ, Johnston JA, Wilson RH, Kay EW, Johnston PG, Olwill SA. The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study. Br J Cancer 2011;105:1487-94. [PMID: 21989182 DOI: 10.1038/bjc.2011.408] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
4 Szwed R, Grzebieniak Z, Saleh Y, Ekonjo GB, Siewinski M. Cysteine peptidase and its inhibitor activity levels and vitamin E concentration in normal human serum and colorectal carcinomas. World J Gastroenterol 2005; 11(6): 850-853 [PMID: 15682479 DOI: 10.3748/wjg.v11.i6.850] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Mazzoccoli G, Vinciguerra M, Papa G, Piepoli A. Circadian clock circuitry in colorectal cancer. World J Gastroenterol 2014; 20(15): 4197-4207 [PMID: 24764658 DOI: 10.3748/wjg.v20.i15.4197] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
6 De Miglio MR, Virdis P, Calvisi DF, Mele D, Muroni MR, Frau M, Pinna F, Tomasi ML, Simile MM, Pascale RM, Feo F. Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/beta-catenin pathway and progression of early lesions in the rat. Carcinogenesis 2007;28:2367-74. [PMID: 17510081 DOI: 10.1093/carcin/bgm119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Segal E, Prestwood TR, van der Linden WA, Carmi Y, Bhattacharya N, Withana N, Verdoes M, Habtezion A, Engleman EG, Bogyo M. Detection of intestinal cancer by local, topical application of a quenched fluorescence probe for cysteine cathepsins. Chem Biol 2015;22:148-58. [PMID: 25579207 DOI: 10.1016/j.chembiol.2014.11.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
8 de Koning PJ, Bovenschen N, Leusink FK, Broekhuizen R, Quadir R, van Gemert JT, Hordijk GJ, Chang WW, van der Tweel I, Tilanus MG, Kummer JA. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome. Int J Cancer 2009;125:1542-50. [DOI: 10.1002/ijc.24507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
9 Binaschi M, Parlani M, Bellarosa D, Bigioni M, Salvatore C, Palma C, Crea A, Maggi CA, Manzini S, Goso C. Human and murine macrophages mediate activation of MEN 4901/T-0128: a new promising camptothecin analogue-polysaccharide conjugate. Anticancer Drugs 2006;17:1119-26. [PMID: 17075311 DOI: 10.1097/01.cad.0000236307.20339.b4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(10): 2446-2449 [DOI: 10.11569/wcjd.v12.i10.2446] [Reference Citation Analysis]
11 Sullivan S, Tosetto M, Kevans D, Coss A, Wang L, O'donoghue D, Hyland J, Sheahan K, Mulcahy H, O'sullivan J. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer. Int J Cancer 2009;125:54-61. [DOI: 10.1002/ijc.24275] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
12 Reinheckel T, Peters C, Krüger A, Turk B, Vasiljeva O. Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target. Front Pharmacol 2012;3:133. [PMID: 22798952 DOI: 10.3389/fphar.2012.00133] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
13 Schleyer KA, Fetrow B, Zannes Fatland P, Liu J, Chaaban M, Ma B, Cui L. Dual-Mechanism Quenched Fluorogenic Probe Provides Selective and Rapid Detection of Cathepsin L Activity*. ChemMedChem 2021;16:1082-7. [PMID: 33295147 DOI: 10.1002/cmdc.202000823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Crotti S, Piccoli M, Rizzolio F, Giordano A, Nitti D, Agostini M. Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? J Cell Physiol. 2017;232:967-975. [PMID: 27775168 DOI: 10.1002/jcp.25658] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 10.8] [Reference Citation Analysis]
15 Sebzda T, Gnus J, Dziadkowiec B, Latka M, Gburek J. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma. World J Gastroenterol 2021; 27(39): 6673-6688 [PMID: 34754160 DOI: 10.3748/wjg.v27.i39.6673] [Reference Citation Analysis]
16 Yao L, Lao W, Zhang Y, Tang X, Hu X, He C, Hu X, Xu LX. Identification of EFEMP2 as a Serum Biomarker for the Early Detection of Colorectal Cancer with Lectin Affinity Capture Assisted Secretome Analysis of Cultured Fresh Tissues. J Proteome Res 2012;11:3281-94. [DOI: 10.1021/pr300020p] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
17 Johnson IR, Parkinson-lawrence EJ, Butler LM, Brooks DA. Prostate cell lines as models for biomarker discovery: Performance of current markers and the search for new biomarkers: Alternative Biomarkers for Prostate Cancer. Prostate 2014;74:547-60. [DOI: 10.1002/pros.22777] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Shoji A, Kabeya M, Ishida Y, Yanagida A, Shibusawa Y, Sugawara M. Evaluation of cathepsin B activity for degrading collagen IV using a surface plasmon resonance method and circular dichroism spectroscopy. J Pharm Biomed Anal 2014;95:47-53. [PMID: 24631956 DOI: 10.1016/j.jpba.2014.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
19 Herszényi L, István G, Cardin R, De Paoli M, Plebani M, Tulassay Z, Farinati F. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Eur J Cancer Prev 2008;17:438-45. [PMID: 18714186 DOI: 10.1097/CEJ.0b013e328305a130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
20 Kuester D, Lippert H, Roessner A, Krueger S. The cathepsin family and their role in colorectal cancer. Pathol Res Pract. 2008;204:491-500. [PMID: 18573619 DOI: 10.1016/j.prp.2008.04.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
21 Gordon PV, Paxton JB, Kuemmerle JF, Fox NS. A 14-kDa cathepsin L-derived carboxyl IGFBP-2 fragment is sequestered by cultured rat ileal crypt cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2005;289:G79-87. [DOI: 10.1152/ajpgi.00384.2004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
22 Xiao T, Ying W, Li L, Hu Z, Ma Y, Jiao L, Ma J, Cai Y, Lin D, Guo S, Han N, Di X, Li M, Zhang D, Su K, Yuan J, Zheng H, Gao M, He J, Shi S, Li W, Xu N, Zhang H, Liu Y, Zhang K, Gao Y, Qian X, Cheng S. An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 2005;4:1480-6. [PMID: 15970581 DOI: 10.1074/mcp.M500055-MCP200] [Cited by in Crossref: 96] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
23 Oliveira CS, Pereira H, Alves S, Castro L, Baltazar F, Chaves SR, Preto A, Côrte-Real M. Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria. Cell Death Dis 2015;6:e1788. [PMID: 26086961 DOI: 10.1038/cddis.2015.157] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
24 Kopansky-Groisman E, Kogan-Zviagin I, Sella-Tavor O, Oron-Herman M, David A. Near-Infrared Fluorescent Activated Polymeric Probe for Imaging Intraluminal Colorectal Cancer Tumors. Biomacromolecules 2019;20:3547-56. [PMID: 31381303 DOI: 10.1021/acs.biomac.9b00806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bratovš A, Kramer L, Mikhaylov G, Vasiljeva O, Turk B. Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery. Biochimie 2019;166:94-102. [PMID: 31163196 DOI: 10.1016/j.biochi.2019.05.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
26 Shoji A, Suenaga Y, Hosaka A, Ishida Y, Yanagida A, Sugawara M. Inhibitory assay for degradation of collagen IV by cathepsin B with a surface plasmon resonance sensor. J Pharm Biomed Anal 2017;145:79-83. [PMID: 28651110 DOI: 10.1016/j.jpba.2017.06.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Herszényi L, Barabás L, Hritz I, István G, Tulassay Z. Impact of proteolytic enzymes in colorectal cancer development and progression. World J Gastroenterol 2014; 20(37): 13246-13257 [PMID: 25309062 DOI: 10.3748/wjg.v20.i37.13246] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
28 Dheer D, Nicolas J, Shankar R. Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases. Advanced Drug Delivery Reviews 2019;151-152:130-51. [DOI: 10.1016/j.addr.2019.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
29 Boudreau F, Lussier CR, Mongrain S, Darsigny M, Drouin JL, Doyon G, Suh ER, Beaulieu JF, Rivard N, Perreault N. Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia. FASEB J 2007;21:3853-65. [PMID: 17622569 DOI: 10.1096/fj.07-8113com] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
30 Tsukamoto T, Iida J, Dobashi Y, Furukawa T, Konishi F. Overexpression in colorectal carcinoma of two lysosomal enzymes, CLN2 and CLN1, involved in neuronal ceroid lipofuscinosis. Cancer 2006;106:1489-97. [DOI: 10.1002/cncr.21764] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
31 Nagaraj NS, Zacharias W. Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells. Toxicol Lett 2007;170:134-45. [PMID: 17399918 DOI: 10.1016/j.toxlet.2007.02.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
32 Higgins WJ, Fox DM, Kowalski PS, Nielsen JE, Worrall DM. Heparin enhances serpin inhibition of the cysteine protease cathepsin L. J Biol Chem 2010;285:3722-9. [PMID: 19959474 DOI: 10.1074/jbc.M109.037358] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
33 Lin WW, Lu YC, Chuang CH, Cheng TL. Ab locks for improving the selectivity and safety of antibody drugs. J Biomed Sci 2020;27:76. [PMID: 32586313 DOI: 10.1186/s12929-020-00652-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sudhan DR, Siemann DW. Cathepsin L targeting in cancer treatment. Pharmacol Ther 2015;155:105-16. [PMID: 26299995 DOI: 10.1016/j.pharmthera.2015.08.007] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 10.4] [Reference Citation Analysis]
35 Chan AT, Baba Y, Shima K, Nosho K, Chung DC, Hung KE, Mahmood U, Madden K, Poss K, Ranieri A. Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia. Cancer Epidemiol Biomarkers Prev. 2010;19:2777-2785. [PMID: 20833970 DOI: 10.1158/1055-9965.EPI-10-0529] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
36 Schleyer KA, Cui L. Molecular probes for selective detection of cysteine cathepsins. Org Biomol Chem 2021;19:6182-205. [PMID: 34288999 DOI: 10.1039/d1ob00225b] [Reference Citation Analysis]
37 Herszényi L, Farinati F, Cardin R, István G, Molnár LD, Hritz I, De Paoli M, Plebani M, Tulassay Z. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer. 2008;8:194. [PMID: 18616803 DOI: 10.1186/1471-2407-8-194] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
38 Kevans D, Wang LM, Sheahan K, Hyland J, O'Donoghue D, Mulcahy H, O'Sullivan J. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Int J Surg Pathol 2011;19:751-60. [PMID: 21791486 DOI: 10.1177/1066896911414566] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
39 Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol 2012;138:501-11. [DOI: 10.1007/s00432-011-1126-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
40 Shubin AV, Demidyuk IV, Kurinov AM, Demkin VV, Vinogradova TV, Zinovyeva MV, Sass AV, Zborovskaya IB, Kostrov SV. Cathepsin D messenger RNA is downregulated in human lung cancer. Biomarkers 2010;15:608-13. [PMID: 20722505 DOI: 10.3109/1354750X.2010.504310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Olson OC, Joyce JA. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer 2015;15:712-29. [PMID: 26597527 DOI: 10.1038/nrc4027] [Cited by in Crossref: 297] [Cited by in F6Publishing: 282] [Article Influence: 49.5] [Reference Citation Analysis]
42 Abdulla MH, Valli-Mohammed MA, Al-Khayal K, Al Shkieh A, Zubaidi A, Ahmad R, Al-Saleh K, Al-Obeed O, McKerrow J. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages. Oncol Rep 2017;37:3175-80. [PMID: 28440429 DOI: 10.3892/or.2017.5576] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
43 Zhang X, Wang X, Xu S, Li X, Ma X. Cathepsin B contributes to radioresistance by enhancing homologous recombination in glioblastoma. Biomed Pharmacother 2018;107:390-6. [PMID: 30099343 DOI: 10.1016/j.biopha.2018.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Liu Y, Li C, Dong L, Chen X, Fan R. Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis. Biosci Rep 2020;40:BSR20200141. [PMID: 32936304 DOI: 10.1042/BSR20200141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Bian B, Mongrain S, Cagnol S, Langlois MJ, Boulanger J, Bernatchez G, Carrier JC, Boudreau F, Rivard N. Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis. Mol Carcinog 2016;55:671-87. [PMID: 25808857 DOI: 10.1002/mc.22312] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]